If you need more lookups,
subscriptions start at $34 USD/month.
Ran Vigdor Location
Israel
Ran Vigdor Work
2019 -now CEO @
2013 -2025 Independent Board Member @
2010 -2012 CEO @
2018 -2019 Chairman of The Board @
2016 -2017 CEO @
2014 -2015 CEO @
2010 -2014 CEO @ TCD Pharma
2008 -2010 Director, Business Development @
2006 -2008 Strategic Alliance Director @ BioCancell Therapeutics Inc.
2003 -2006 Founder, Business Development Officer @ Arakis Water Infrastructures Ltd.
Ran Vigdor Education
IE Business School
(MBA, International Executive MBA)
2008-2009
The Hebrew University of Jerusalem
(LL.B, Law)
The Hebrew University of Jerusalem
(B.A, Business Administration)
Ran Vigdor Skills
Biotechnology
Venture Capital
Technology Transfer
Lifesciences
Corporate Development
Pharmaceutical Industry
Start-ups
Strategy
Commercialization
Business Development
Executive Management
Mergers & Acquisitions
Medical Devices
Strategic Partnerships
Product Launch
Marketing
Management
Business Strategy
Business Planning
Entrepreneurship
Strategic Planning
Biopharmaceuticals
Competitive Analysis
International Business
Market Analysis
Financial Modeling
Oncology
Negotiation
Licensing
Due Diligence
Global Business Development
Drug Development
Clinical Development
Genomics
Private Equity
Strategic Consulting
Strategic Alliances
M&A experience
Competitive Intelligence
Angel Investing
Global Marketing
Venture Financing
Innovation Management
Investor Relations
Drug Discovery
Cleantech
Life Sciences
Start Ups
Global Business
Program Management
Time Management
Mergers and Acquisitions
Ran Vigdor Summary
Ran Vigdor, based in Israel, is currently a CEO at Trima Pharmaceutical Products. Ran Vigdor brings experience from previous roles at Amadix and Tiltan Pharma. Ran Vigdor holds a 2008 - 2009 IE Business School. With a robust skill set that includes Biotechnology, Venture Capital, Technology Transfer, Lifesciences, Corporate Development and more. Ran Vigdor has 2 emails on RocketReach.
Looking for a different Ran Vigdor?
Find contact details for 700 million professionals.